Endonovo Therapeutics Inc. (ENDV) 1.7500 $ENDV
Endeavour Receives Notice Regarding NYSE Continued Listing Standards
PR Newswire - Wed Sep 17, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) announced today that the New York Stock Exchange ("NYSE"
has notified the Company that it is not in compliance with two of the NYSE's continued listing standards.
Endeavour Announces Rochelle Field Offline
PR Newswire - Mon Sep 15, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Rochelle field is offline until repairs to the dry gas export compressors on the Scott platform are completed.
Endeavour Announces Decision Not to Make Interest Payments
PR Newswire - Tue Sep 02, 3:05PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has decided not to pay approximately $33.5 million in interest due on September 2, 2014 on its 12% First Priority Notes due March 2018, 12% Second Priority Notes due June 2018 and 6.5% Convertible Senior Notes due November 2017 ("collectively, the Notes" . Under the term of the indentures for the Notes, there is a 30-day grace period during which the Company may elect to make the interest payment and cure any potential event of default for non-payment.
Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
Marketwire - Tue Sep 02, 8:02AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic technologies, devices and therapies (the "Technology" .
Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy for Urinary Incontinence
Marketwire - Thu Aug 14, 8:03AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company" , a developer of non-invasive bioelectronic therapies, announced today that it has retained Holland & Knight, LLP ("H & K" as its legal counsel and Emergo Group, Inc. ("Emergo" to assist the Company in obtaining FDA clearance of its non-invasive urinary incontinence treatment.
Endeavour to Present at EnerCom's The Oil and Gas Conference
PR Newswire - Tue Aug 12, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at EnerCom's The Oil and Gas Conference being held in Denver, Colorado. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Wednesday, August 20, 2014 at 10:05am Mountain time.
Endeavour Announces 2014 Second Quarter Financial and Operational Results
PR Newswire - Tue Aug 05, 1:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported physical production for the quarter that exceeded the Company's revised guidance range of 10,500 - 11,500 barrels of oil equivalent per day ("boepd" previously announced on June 10, 2014. Physical production for the second quarter of 2014 averaged 12,900 boepd compared to 9,500 boepd for the same quarter of 2013. Sales volumes for the second quarter of 2014 were 7,400 boepd, compared to 14,500 boepd for the same quarter in the prior year.
Endeavour Schedules 2014 Second Quarter Conference Call and Webcast
PR Newswire - Mon Jul 28, 4:37PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) will host a conference call and webcast to discuss its 2014 second quarter financial and operating results on Tuesday, August 5, 2014 at 9 a.m. Central Time, 3 p.m. British Summer Time.
Endeavour to Present at the Howard Weil Energy Conference
PR Newswire - Tue Mar 25, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at the Howard Weil's 42nd Annual Energy Conference. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Thursday, March 27, 2014 at 11:00 am Central time.
Endeavour Announces New Board Member
PR Newswire - Wed Mar 19, 3:29PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that James H. Browning has been appointed to a serve as a Director on the company's Board of Directors. He will serve as an independent director and be appointed to both the Technology & Reserves Committee and Audit Committee, where he qualifies as an "audit committee financial expert."
Endeavour Announces 2013 Fourth Quarter and Year-End Financial and Operational Results
PR Newswire - Wed Mar 05, 1:00AM CST
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported fourth quarter 2013 net loss, as adjusted of $24.7 million compared to a net loss, as adjusted of $7.7 million for the same period in 2012. On a GAAP basis, net loss for the fourth quarter was $27.7 million as compared to net loss of $6.5 million for the same quarter in 2012.
Endeavour Receives Notice Regarding NYSE Continued Listing Standards
PR Newswire - Wed Sep 17, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) announced today that the New York Stock Exchange ("NYSE"
has notified the Company that it is not in compliance with two of the NYSE's continued listing standards. Endeavour Announces Rochelle Field Offline
PR Newswire - Mon Sep 15, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Rochelle field is offline until repairs to the dry gas export compressors on the Scott platform are completed.
Endeavour Announces Decision Not to Make Interest Payments
PR Newswire - Tue Sep 02, 3:05PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has decided not to pay approximately $33.5 million in interest due on September 2, 2014 on its 12% First Priority Notes due March 2018, 12% Second Priority Notes due June 2018 and 6.5% Convertible Senior Notes due November 2017 ("collectively, the Notes"
. Under the term of the indentures for the Notes, there is a 30-day grace period during which the Company may elect to make the interest payment and cure any potential event of default for non-payment. Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
Marketwire - Tue Sep 02, 8:02AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic technologies, devices and therapies (the "Technology"
. Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy for Urinary Incontinence
Marketwire - Thu Aug 14, 8:03AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
, a developer of non-invasive bioelectronic therapies, announced today that it has retained Holland & Knight, LLP ("H & K" as its legal counsel and Emergo Group, Inc. ("Emergo" to assist the Company in obtaining FDA clearance of its non-invasive urinary incontinence treatment. Endeavour to Present at EnerCom's The Oil and Gas Conference
PR Newswire - Tue Aug 12, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at EnerCom's The Oil and Gas Conference being held in Denver, Colorado. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Wednesday, August 20, 2014 at 10:05am Mountain time.
Endeavour Announces 2014 Second Quarter Financial and Operational Results
PR Newswire - Tue Aug 05, 1:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported physical production for the quarter that exceeded the Company's revised guidance range of 10,500 - 11,500 barrels of oil equivalent per day ("boepd"
previously announced on June 10, 2014. Physical production for the second quarter of 2014 averaged 12,900 boepd compared to 9,500 boepd for the same quarter of 2013. Sales volumes for the second quarter of 2014 were 7,400 boepd, compared to 14,500 boepd for the same quarter in the prior year. Endeavour Schedules 2014 Second Quarter Conference Call and Webcast
PR Newswire - Mon Jul 28, 4:37PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) will host a conference call and webcast to discuss its 2014 second quarter financial and operating results on Tuesday, August 5, 2014 at 9 a.m. Central Time, 3 p.m. British Summer Time.
Endeavour to Present at the Howard Weil Energy Conference
PR Newswire - Tue Mar 25, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at the Howard Weil's 42nd Annual Energy Conference. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Thursday, March 27, 2014 at 11:00 am Central time.
Endeavour Announces New Board Member
PR Newswire - Wed Mar 19, 3:29PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that James H. Browning has been appointed to a serve as a Director on the company's Board of Directors. He will serve as an independent director and be appointed to both the Technology & Reserves Committee and Audit Committee, where he qualifies as an "audit committee financial expert."
Endeavour Announces 2013 Fourth Quarter and Year-End Financial and Operational Results
PR Newswire - Wed Mar 05, 1:00AM CST
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported fourth quarter 2013 net loss, as adjusted of $24.7 million compared to a net loss, as adjusted of $7.7 million for the same period in 2012. On a GAAP basis, net loss for the fourth quarter was $27.7 million as compared to net loss of $6.5 million for the same quarter in 2012.
